Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,retainedEarnings,otherLiab,goodWill,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,totalCurrentAssets,netReceivables,accountsPayable,commonStock,longTermDebt,changeToLiabilities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,changeToAccountReceivables,changeToNetincome,totalCashflowsFromInvestingActivities,otherCashflowsFromInvestingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,exchange,currency,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,marketState,market,shortName,exchangeDataDelayedBy,esgPopulated,tradeable,priceHint,regularMarketChangePercent,regularMarketDayRange,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,KALTF,-6745000.0,707516992,,,-2777000,,-2301000,159000,0,-159000,-159000,,-59000,,,,-476000,0,159000,0,-2618000,,-2301000,-2301000,5627000.0,57484000.0,7933000.0,176000.0,4278000.0,8109000.0,-57308000.0,1295000.0,1294000.0,5000.0,28000.0,6638000.0,406000.0,1183000.0,108000.0,951000.0,,,-433000.0,-10000.0,347000.0,-13000.0,357000.0,23000.0,-324000.0,-185000.0,2608000.0,,,-5455000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,0.2563,1630524278,-0.013700008,0.26391,0.2831,0.2563,12689,0.27,0.0,0.0,0,0,finmb_292313994,Other OTC,"Claritas Pharmaceuticals, Inc.",USD,11003,8023,0.2555,319.375,8.0E-4 - 2.0,-1.7437,-0.87185,0.0008,2.0,1484092800,PRE,us_market,CLARITAS PHARMACEUTICALS INC,0,False,False,4,-5.074077,0.2563 - 0.2831,-0.022,0.0,0.32718334,-0.07088333,-0.21664713,0.56487834,-0.30857834,-0.546274,200838464,15,America/New_York,EDT,-14400000,2.84,,,2.0,0.0008,0.3272,0.5649,11k,8.02k,707.52M,,699.44M,0.28%,1.03%,,,,,,,,,,,0.00%,"Jan 10, 2017",,1:20,"Jul 22, 2021","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,2.18%,-215.70%,,,,,,-12.03M,-0.0220,,28k,0,406k,230.68,0.18,0.00,-607k,-1.97M,Value,94903,Healthcare,"Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.",San Rafael,888 861 2008,CA,1609372800,United States,http://claritaspharma.com,86400,4040 Civic Center Drive,Biotechnology,Suite 200
t-1,KALTF,-7957000.0,707516992,-2340000.0,,-598000,,-654000,348000,0,1992000,1992000,,-2911000,,,,56000,0,-1992000,0,-2590000,,-654000,-654000,7694000.0,56514000.0,8938000.0,1507000.0,4223000.0,10445000.0,-55007000.0,1810000.0,1770000.0,6000.0,5000.0,7128000.0,925000.0,975000.0,206000.0,908000.0,56514000.0,40000.0,97000.0,-10000.0,347000.0,-71000.0,357000.0,-485000.0,-484000.0,-41000.0,185000.0,-1000.0,-1000.0,-6153000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,0.2563,1630524278,-0.013700008,0.26391,0.2831,0.2563,12689,0.27,0.0,0.0,0,0,finmb_292313994,Other OTC,"Claritas Pharmaceuticals, Inc.",USD,11003,8023,0.2555,319.375,8.0E-4 - 2.0,-1.7437,-0.87185,0.0008,2.0,1484092800,PRE,us_market,CLARITAS PHARMACEUTICALS INC,0,False,False,4,-5.074077,0.2563 - 0.2831,-0.022,0.0,0.32718334,-0.07088333,-0.21664713,0.56487834,-0.30857834,-0.546274,200838464,15,America/New_York,EDT,-14400000,2.84,,,2.0,0.0008,0.3272,0.5649,11k,8.02k,707.52M,,699.44M,0.28%,1.03%,,,,,,,,,,,0.00%,"Jan 10, 2017",,1:20,"Jul 22, 2021","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,2.18%,-215.70%,,,,,,-12.03M,-0.0220,,28k,0,406k,230.68,0.18,0.00,-607k,-1.97M,Value,94903,Healthcare,"Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.",San Rafael,888 861 2008,CA,1609372800,United States,http://claritaspharma.com,86400,4040 Civic Center Drive,Biotechnology,Suite 200
t-2,KALTF,-7419000.0,707516992,14000.0,,-1022000,,-413000,822000,0,-836000,-836000,,-152000,,,,-609000,0,836000,0,-186000,,-413000,-413000,7873000.0,56618000.0,8620000.0,2265000.0,4166000.0,10885000.0,-54353000.0,1774000.0,1811000.0,546000.0,490000.0,6777000.0,826000.0,655000.0,165000.0,864000.0,,69000.0,-1174000.0,-10000.0,212000.0,-489000.0,212000.0,479000.0,267000.0,-35000.0,2378000.0,-1000.0,-1000.0,-6122000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,0.2563,1630524278,-0.013700008,0.26391,0.2831,0.2563,12689,0.27,0.0,0.0,0,0,finmb_292313994,Other OTC,"Claritas Pharmaceuticals, Inc.",USD,11003,8023,0.2555,319.375,8.0E-4 - 2.0,-1.7437,-0.87185,0.0008,2.0,1484092800,PRE,us_market,CLARITAS PHARMACEUTICALS INC,0,False,False,4,-5.074077,0.2563 - 0.2831,-0.022,0.0,0.32718334,-0.07088333,-0.21664713,0.56487834,-0.30857834,-0.546274,200838464,15,America/New_York,EDT,-14400000,2.84,,,2.0,0.0008,0.3272,0.5649,11k,8.02k,707.52M,,699.44M,0.28%,1.03%,,,,,,,,,,,0.00%,"Jan 10, 2017",,1:20,"Jul 22, 2021","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,2.18%,-215.70%,,,,,,-12.03M,-0.0220,,28k,0,406k,230.68,0.18,0.00,-607k,-1.97M,Value,94903,Healthcare,"Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.",San Rafael,888 861 2008,CA,1609372800,United States,http://claritaspharma.com,86400,4040 Civic Center Drive,Biotechnology,Suite 200
t-3,KALTF,-10484000.0,707516992,74000.0,,-12986000,,-8666000,368000,0,-442000,-442000,,-399000,,,,-4320000,0,442000,0,-12544000,,-8666000,-8666000,10523000.0,56399000.0,10630000.0,2459000.0,4110000.0,13089000.0,-53940000.0,3390000.0,2420000.0,5000.0,11000.0,7172000.0,760000.0,141000.0,130000.0,1433000.0,,68000.0,-4206000.0,68000.0,68000.0,183000.0,212000.0,8000.0,-66000.0,-14000.0,12637000.0,6000.0,6000.0,-7031000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,0.2563,1630524278,-0.013700008,0.26391,0.2831,0.2563,12689,0.27,0.0,0.0,0,0,finmb_292313994,Other OTC,"Claritas Pharmaceuticals, Inc.",USD,11003,8023,0.2555,319.375,8.0E-4 - 2.0,-1.7437,-0.87185,0.0008,2.0,1484092800,PRE,us_market,CLARITAS PHARMACEUTICALS INC,0,False,False,4,-5.074077,0.2563 - 0.2831,-0.022,0.0,0.32718334,-0.07088333,-0.21664713,0.56487834,-0.30857834,-0.546274,200838464,15,America/New_York,EDT,-14400000,2.84,,,2.0,0.0008,0.3272,0.5649,11k,8.02k,707.52M,,699.44M,0.28%,1.03%,,,,,,,,,,,0.00%,"Jan 10, 2017",,1:20,"Jul 22, 2021","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,2.18%,-215.70%,,,,,,-12.03M,-0.0220,,28k,0,406k,230.68,0.18,0.00,-607k,-1.97M,Value,94903,Healthcare,"Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.",San Rafael,888 861 2008,CA,1609372800,United States,http://claritaspharma.com,86400,4040 Civic Center Drive,Biotechnology,Suite 200
